Holen Sie sich die Stockscreener-App
0.224
6.57%
0.0138
Handel nachbörslich:
.21
-0.014
-6.25%
Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.03%
1.051
|
0.982 | 2.567 | 2.511 | 3.076 |
| Operating Expenses |
4.72%
31.54
|
30.12 | 26.43 | 39.56 | 41.73 |
| Interest Income/Expense |
1.45%
0.699
|
0.689 | 0.702 | 0.699 | 0.689 |
| Operating Income/Loss |
4.65%
-30.49
|
-29.14 | -23.86 | -37.05 | -38.65 |
| Net Income/Loss |
5.91%
-30.36
|
-28.67 | -22.98 | -35.71 | -36.95 |
| Basic Average Shares |
0.03%
129.95
|
129.91 | 0.0285 | 129.84 | 129.73 |
| Diluted Average Shares |
0.03%
129.95
|
129.91 | 0.0285 | 129.84 | 129.73 |
| Basic Earnings Per Share |
4.55%
-0.23
|
-0.22 | -0.18 | -0.28 | -0.28 |
| Diluted Earnings Per Share |
4.55%
-0.23
|
-0.22 | -0.18 | -0.28 | -0.28 |
1.08%
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):